129451-62-3Relevant articles and documents
MUTANT VIRUS, PREPARATION METHOD THEREFOR AND APPLICATION THEREOF
-
Paragraph 0146; 0148, (2020/09/09)
The present invention relates to a mutated virus. Said virus can be an influenza virus of human or other animal origin. The present invention also relates to a method for preparing the mutated virus, the method comprising introducing UAG codons into positions upstream of the stop codons per se of one or more genes of a viral genome by reverse genetic techniques. The present invention further relates to uses of the mutated virus, for example, as a live attenuated vaccine, or in replication of controllable and safe virus models, and the like.
Triterpene derivative and application thereof in resistance to Ebola virus
-
Paragraph 0094; 0096, (2017/11/30)
The invention relates to a use of a triterpene derivative shown in a formula in preparation of a medicine used for preventing or treating an Ebola disease. The triterpene derivative has obvious inhibitory effect on the Ebola virus, can obviously inhibit the Ebola virus from entering a cell and can be used for preventing or treating Ebola. The invention also provides a new triterpene compound which can inhibit the Ebola virus. (The formula is described in the specification.).